NDC 0378-6857 – Lisdexamfetamine Dimesylate

Lisdexamfetamine Dimesylate 40 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CII

Product NDC0378-6857

Product details

Brand name
Lisdexamfetamine Dimesylate
Generic name
lisdexamfetamine
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA202835
Marketed since
August 25, 2023
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for lisdexamfetamine dimesylate →

Package NDC codes (1)

Package NDCDescriptionSince
0378-6857-7790 CAPSULE in 1 BOTTLE, PLASTIC (0378-6857-77)Aug 25, 2023

Other lisdexamfetamine dimesylate products